DPP-4 inhibition protects human umbilical vein endothelial cells from hypoxia-induced vascular barrier impairment
Authors:
Open Access
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 135 (1) , 29-36
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Soluble CD26/Dipeptidyl Peptidase IV Enhances the Transcription of IL-6 and TNF-α in THP-1 Cells and MonocytesPLOS ONE, 2013
- Nitrite-Mediated S -Nitrosylation of Caspase-3 Prevents Hypoxia-Induced Endothelial Barrier DysfunctionCirculation Research, 2011
- Molecular Insights and Therapeutic Targets for Diabetic Endothelial DysfunctionCirculation, 2009
- The role of adherens junctions and VE-cadherin in the control of vascular permeabilityJournal of Cell Science, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Proteolytic Degradation of VE-Cadherin Alters the Blood-Retinal Barrier in DiabetesDiabetes, 2007
- Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activityProceedings of the National Academy of Sciences, 2006
- Re-solving the Cadherin-Catenin-Actin ConundrumJournal of Biological Chemistry, 2006
- Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26Blood, 2006
- Prolonged hypoxia alters endothelial barrier functionSurgery, 1998